Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neoplasm Metastasis 1Lung Neoplasms 1Hip Fractures 1Glioma 1Glioblastoma 1Fractures, Spontaneous 1Financial Stress 1Dysplastic Nevus Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1COVID-19 1Breast Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1Ataxia Telangiectasia 1

Interventions

Gemcitabine 57130-nm albumin-bound paclitaxel 35Specimen Handling 26Magnetic Resonance Spectroscopy 21Albumin-Bound Paclitaxel 21Fluorouracil 20Leucovorin 19Irinotecan 19Oxaliplatin 17Biopsy 17Taxes 16pembrolizumab 14Cyclophosphamide 12Cisplatin 11fludarabine 10Cetuximab 9Capecitabine 8Radiosurgery 7Nivolumab 7Carboplatin 7irinotecan sucrosofate 6durvalumab 6dehydroftorafur 6Pemetrexed 6olaparib 5Ipilimumab 5Erlotinib Hydrochloride 5trastuzumab deruxtecan 4aldesleukin 4Radiotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Data Collection × 90 days × Clear all
NCT05687188 2026-05-26

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

H. Lee Moffitt Cancer Center and Research Institute

Recruiting
125 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡